Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
1
33%
Ph early_phase_1
1
33%
Ph phase_2
1
33%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (33.3%)
Phase 11 (33.3%)
Phase 21 (33.3%)

Trials by Status

unknown267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnearly_phase_1

Stem Cells for Bronchopulmonary Dysplasia

NCT03378063
unknownphase_1

Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia

NCT03558334
unknownphase_2

Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia

NCT03601416

Clinical Trials (3)

Showing 3 of 3 trials
NCT03378063Early Phase 1

Stem Cells for Bronchopulmonary Dysplasia

Withdrawn
NCT03558334Phase 1

Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia

Unknown
NCT03601416Phase 2

Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3